Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Cash flows from operating activities
Net loss	$ (4,369,094)	$ (3,477,202)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	9,634	1,325
Amortization	318,609	318,609
Stock-based compensation - employees	514,600
Stock-based compensation - others	77,500
Non-cash interest expense	1,790,975	1,448,628
Non-cash interest expense – related parties	316,284	246,295
Deferred lease expense	40,728	40,726
Foreign exchange (gain) loss	(32,433)	93,237
Changes in operating assets and liabilities which provided (used) cash:
Other receivables	(241,344)	(122,861)
Accounts payable	109,454	(147,052)
Accrued expenses	75,303	278,694
Net cash used in operating activities	(1,389,784)	(1,319,601)
Cash flows from investing activities
Advance on business acquisition	(100,000)	(350,000)
Leasehold improvements in progress	(5,439)	(142,371)
Net cash used in investing activities	(105,439)	(492,371)
Cash flows from financing activities
Issuance of loans payable	380,000
Repayment of loans payable	(230,000)
Issuance of loans payable - related parties	225,000
Issuance of convertible notes	1,227,064
Repayment of convertible notes	(21,600)
Issuance of convertible notes - related parties		1,809,980
Net cash provided by financing activities	1,580,464	1,809,980
Net increase (decrease) in cash and cash equivalents	85,241	(1,992)
Cash and cash equivalents, beginning of period	84,978	62,381
Cash and cash equivalents, end of period	170,219	60,389
Supplemental cash flows disclosures
Cash paid for interest	33,055	68,129
Non-cash transactions - investing and financing activities
Patent acquisition liability modification	4,380,000
Conversion of rents due to convertible loan		230,786
Accrued expense converted to convertible loans		$ 831,628